Citigroup Inc Nanobiotix S.A. Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Nanobiotix S.A. stock. As of the latest transaction made, Citigroup Inc holds 241 shares of NBTX stock, worth $1,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
241
Previous 241
-0.0%
Holding current value
$1,176
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NBTX
# of Institutions
13Shares Held
6MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$27.4 Million6.69% of portfolio
-
Black Rock Inc. New York, NY239KShares$1.17 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY105KShares$512,6580.02% of portfolio
-
Jane Street Group, LLC New York, NY11.4KShares$55,5680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$49,6970.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $170M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...